Authors: Fettiplace MR et al.
Anesthesia & Analgesia, 142(5):843–846, May 2026
Summary:
This editorial examines the ongoing debate regarding the optimal anesthetic technique for geriatric hip fracture surgery, focusing on the apparent discrepancy between observational studies and randomized controlled trials (RCTs). While large observational datasets often suggest improved outcomes with neuraxial anesthesia, high-quality RCTs have consistently shown no significant difference between neuraxial and general anesthesia.
The authors review the physiologic rationale for neuraxial anesthesia, including avoidance of mechanical ventilation, reduced opioid use, improved lower-extremity blood flow, and attenuation of the stress response. These theoretical benefits have historically supported the belief that neuraxial techniques may reduce complications such as pulmonary events, thromboembolism, and cardiac morbidity. However, landmark trials such as REGAIN and RAGA have failed to demonstrate meaningful differences in mortality, delirium, or functional recovery between neuraxial and general anesthesia, even at longer follow-up intervals.
Recent observational studies, including large national datasets from China and the United States, have reported modest benefits with neuraxial anesthesia, including lower mortality, fewer thromboembolic events, and reduced readmissions. However, the authors highlight critical limitations of these studies, particularly residual confounding despite propensity matching. For example, differences in hospital procedural volume—a known determinant of outcomes—may explain observed benefits rather than the anesthetic technique itself. Additionally, patient selection bias may influence results, as sicker or more complex patients are often excluded from RCTs but included in observational datasets.
The article emphasizes that observational studies, regardless of size, cannot replace randomized evidence. Even small imbalances in confounding variables can produce statistically significant but clinically modest differences. Furthermore, improvements in modern anesthetic practice—such as better ventilation strategies, multimodal analgesia, and enhanced recovery protocols—have likely reduced differences between anesthetic techniques over time.
The authors conclude that both neuraxial and general anesthesia are reasonable and safe options for geriatric hip fracture surgery. Neuraxial anesthesia may offer modest advantages in selected high-risk patients, but the evidence does not support a universal preference. Instead, anesthetic choice should be individualized based on patient comorbidities, surgical factors, contraindications, and clinician expertise.
What You Should Know:
Observational studies often suggest benefits of neuraxial anesthesia in hip fracture surgery, but randomized trials do not confirm these findings. Differences may be driven by confounding factors rather than true treatment effects. Both neuraxial and general anesthesia are safe options, and anesthetic choice should be individualized rather than protocol-driven.
Key Points:
- Editorial addressing discrepancy between observational data and RCTs
- RCTs (REGAIN, RAGA) show no major outcome differences
- Observational studies suggest modest benefits with neuraxial anesthesia
- Residual confounding and selection bias limit observational conclusions
- Hospital volume and patient selection may influence results
- Both anesthetic techniques are safe and acceptable
- Individualized, patient-centered decision-making is recommended
Thank you to Anesthesia & Analgesia for allowing us to summarize this article.